Mesenchymal Stem Cell Secretome for Lung Fibrosis Post Covid-19 Infection-Case Report

Stefan Nugroho; Verdi Danutirto; Rouna Yauwenas; Sandy Qlintang; Petrus Fransiskus Cristanto Tan

doi:10.2991/978-94-6463-060-2_18

<Previous Article In Volume

Next Article In Volume>

Mesenchymal Stem Cell Secretome for Lung Fibrosis Post Covid-19 Infection-Case Report

Authors

Stefan Nugroho¹, Verdi Danutirto², Rouna Yauwenas¹, Sandy Qlintang¹^{, *}, Petrus Fransiskus Cristanto Tan²

¹Stem Cell and Cancer Institute, Kalbe Farma, Jakarta, Indonesia

²Mitra Keluarga Hospital West Bekasi, Bekasi, West Java, Indonesia

^*Corresponding author. Email: sandy.qlintang@kalbe.co.id

Corresponding Author

Sandy Qlintang

Available Online 16 December 2022.

DOI: 10.2991/978-94-6463-060-2_18 How to use a DOI?
Keywords: Covid-19; Secretome; Lung fibrosis
Abstract: Covid-19 has been a global health emergency and not only induced an unprecedented economic crisis in almost every country, but has led to social and educational crises. With the fast spreading and mutation rate of this virus, human lifestyle has been changed to mitigate the infection of SARS-CoV-2. However, this virus is still able to infect vaccinated people, thus reducing their quality of life for those who have post covid syndrome. In this case report, we report 3 case studies of Mesenchymal Stem Cell Secretome to reduce lung fibrosis post covid in humans. All patients who tested negative after being infected by SARS-CoV-2 have breathing difficulty and weakness as the symptoms of post covid syndrome, then intramuscular Mesenchymal Stem Cell Secretome injections were administered and patients were monitored closely to see its effectiveness. After 1 month from the last injection, all patients were able to breathe normally, shown by reduction of lung fibrosis sasasa.
Copyright: © 2023 The Author(s)
Open Access: Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume

Next Article In Volume>

Volume Title: Proceedings of The 13th Annual Scientific Conference of Medical Faculty, Universitas Jenderal Achmad Yani (ASCMF 2022)
Series: Advances in Health Sciences Research
Publication Date: 16 December 2022
ISBN: 10.2991/978-94-6463-060-2_18
ISSN: 2468-5739
DOI: 10.2991/978-94-6463-060-2_18 How to use a DOI?
Open Access: Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

ris enw bib

TY  - CONF
AU  - Stefan Nugroho
AU  - Verdi Danutirto
AU  - Rouna Yauwenas
AU  - Sandy Qlintang
AU  - Petrus Fransiskus Cristanto Tan
PY  - 2022
DA  - 2022/12/16
TI  - Mesenchymal Stem Cell Secretome for Lung Fibrosis Post Covid-19 Infection-Case Report
BT  - Proceedings of The 13th Annual Scientific Conference of Medical Faculty, Universitas Jenderal Achmad Yani (ASCMF 2022)
PB  - Atlantis Press
SP  - 126
EP  - 133
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-060-2_18
DO  - 10.2991/978-94-6463-060-2_18
ID  - Nugroho2022
ER  -

download .riscopy to clipboard